Work

Initial high-efficacy disease-modifying therapy in multiple sclerosis

Year: 2020

Type: article

Study design: Observational Study

Source: Neurology

DOI: 10.1212/wnl.0000000000010135

Authors: Mathias Due Buron, Thor Ameri Chalmer, Finn Sellebjerg, Ismael Barzinji, Danny Bech, Jeppe Romme Christensen, Mette Kirstine Christensen, Victoria Hansen, Zsolt Illes, Henrik Boye Jensen, Matthias Kant, Viktoria Papp, Thor Petersen, Sivagini Prakash, Peter Vestergaard Rasmussen, Jakob Schäfer, Ásta Theódórsdóttir, Arkadiusz Weglewski, Per Soelberg Sorensen, Melinda Magyari

Institutions: Aalborg University Hospital, Aarhus University Hospital, Rigshospitalet, Danish Multiple Sclerosis Center, Odense University Hospital, University of Southern Denmark, Herlev Hospital

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3041766698

FWCI: 12.98

Cites: 36

Cited by: 163

Related to: 10